Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
203.13%
operating margin TTM
-1480.04%
revenue TTM
130.68 Thousand
revenue per share TTM
0.22$
valuation ratios | |
|---|---|
| pe ratio | 0.08 |
| peg ratio | 0.00 |
| price to book ratio | -0.01 |
| price to sales ratio | 0.11 |
| enterprise value multiple | -2.27 |
| price fair value | -0.01 |
profitability ratios | |
|---|---|
| gross profit margin | 60.33% |
| operating profit margin | -1480.04% |
| pretax profit margin | 203.13% |
| net profit margin | 203.13% |
| return on assets | 171.82% |
| return on equity | -13.07% |
| return on capital employed | 105.95% |
liquidity ratio | |
|---|---|
| current ratio | 0.08 |
| quick ratio | 0.08 |
| cash ratio | 0.01 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 34.07 |
| days of payables outstanding | 7,165.69 |
| cash conversion cycle | -7,131.62 |
| receivables turnover | 10.71 |
| payables turnover | 0.05 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 4.27 |
| debt equity ratio | -0.36 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | -0.57 |
| interest coverage | -278.58 |
| cash flow to debt ratio | -1.31 |
cash flow ratios | |
|---|---|
| free cash flow per share | -15.36 |
| cash per share | 0.34 |
| operating cash flow per share | -15.36 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -1.31 |
| short term coverage ratios | -1.31 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time Seelos Therapeutics, Inc. (NASDAQ:SEEL) reported earnings?
Seelos Therapeutics, Inc. (SEEL) published its most recent earnings results on 14-08-2024.
What is Seelos Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Seelos Therapeutics, Inc. (NASDAQ:SEEL)'s trailing twelve months ROE is -13.07%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Seelos Therapeutics, Inc. (SEEL) currently has a ROA of 171.82%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did SEEL's net profit margin stand at?
SEEL reported a profit margin of 203.13% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is SEEL's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.08 in the most recent quarter. The quick ratio stood at 0.08, with a Debt/Eq ratio of -0.36.